Cutting-edge innovation driven by our purpose
Since 2014, Freenome has had a clear vision—to detect cancer in its earliest, most treatable stages.
We are values-led
At Freenome, our values guide everything we do.
STRIVE FOR GREATNESS
We choose to take on cancer not because it’s easy, but because it’s hard.
SERVANT LEADERSHIP
We lead by example and help others grow to their full potential.
TRUST
We recognize trust is built over time and value long-term relationships, not short-term transactions.
INTEGRITY
We courageously do what is right, and are fact-based, data-driven, and accountable for results.
EMPATHY
We seek to understand before being understood and build products that equitably serve diverse communities.
Leadership
Aaron Elliott, Ph.D.
Chief Executive Officer
Riley Ennis
Co-Founder and
Chief Product Officer
Thomas Fitzpatrick
Chief Legal Officer
Robert Guigley
Chief Commercial Officer
Linh H. Le
Chief Financial Officer
Jimmy Lin, M.D., Ph.D., MHS
Chief Scientific Officer
Julie Tran, MSHR
Chief People Officer
Sally Howard
Senior Vice President,
Regulatory and Quality
Advisors
Carmen E. Guerra, MD, MSCE, FACP
University of Pennsylvania Perelman School of Medicine
Samir Gupta, MD, MSCS
University of California San Diego
Doug Robertson, MD, MPH
Geisel School of Medicine at Dartmouth
Robert E. Schoen, MD, MPH
University of Pittsburgh
Aasma Shaukat MD, MPH, NYU
Grossman School of Medicine
Carmen E. Guerra, MD, MSCE, FACP
University of Pennsylvania Perelman School of Medicine
Samir Gupta, MD, MSCS
University of California San Diego
Doug Robertson, MD, MPH
Geisel School of Medicine at Dartmouth
Robert E. Schoen, MD, MPH
University of Pittsburgh
Aasma Shaukat MD, MPH, NYU
Grossman School of Medicine
Investors
* Funds and accounts advised by T. Rowe Price Associates, Inc.